SW
PRPH

SVB Wealth’s ProPhase Labs PRPH Stock Holding History

SVB Wealth’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,767
Closed -$19.3K – 1327
2025
Q1 		$19.3K Hold
4,767
– – ﹤0.01% 755
2024
Q4 		$36.1K Buy
+4,767
New +$66.9K ﹤0.01% 739
2024
Q3 		– Sell
-4,767
Closed -$199K – 450
2024
Q2 		$199K Hold
4,767
– – ﹤0.01% 678
2024
Q1 		$308K Hold
4,767
– – 0.01% 622
2023
Q4 		$215K Hold
4,767
– – 0.01% 744
2023
Q3 		$208K Buy
+4,767
New +$279K ﹤0.01% 732

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

SVB Wealth's PRPH Position: Q2 2025 in Review

SVB Wealth sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 4,767 shares — an estimated $19.3K sold.

SVB Wealth first reported a position in PRPH in Q3 2023 and held it in 6 quarters. The position peaked at $308K in Q1 2024. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • SVB Wealth reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • SVB Wealth sold 4,767 ProPhase Labs shares in Q2 2025, an estimated $19.3K.
  • SVB Wealth first reported a position in ProPhase Labs in Q3 2023 and held it in 6 quarters.
  • SVB Wealth's ProPhase Labs position peaked at $308K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.